|
Cholangitis in Viral Diseases
|
|
|
Insulin Resistance and Platelet Count/Spleen Diameter Ratio for predicting esophageal varices in HEPATITIS C VIRUS Cirrhosis
|
|
|
Association of serum YKL-40 levels with urinary albumin in
Egyptian patients with type 1 diabetes mellitus
|
|
GOLGI PROTEIN 73 (GP73) mRNA EXPRESSION AS A SERUM MARKER FOR DETECTION OF
HEPATOCELLULAR CARCINOMA AMONG EGYPTIAN PATIENTS
|
|
SERUM PROLACTIN LEVEL AS A BIOLOGICAL MARKER
OF SEVERITY IN LIVER CIRRHOSIS
|
|
Clinical Outcome of Exocrine Pancreatic Adenocarcinoma: A Single Center Experience
|
|
Clinical Outcome of Exocrine Pancreatic Adenocarcinoma: A Single Center Experience
|
|
NONINVASIVE BRAIN STIMULATION FOR PARKINSON’S DISEASE
|
|
Relation between Interleukin -4 (590C/T) Gene Polymorphism
and Hepatocellular Carcinoma Risk in HBV and HCV Patients
|
|
CHRONIC LOW BACK PAIN & PSYCHOLOGICAL COMORBIDITY
|
|
Relation between Interleukin -4 (590C/T) Gene Polymorphism and Hepatocellular Carcinoma Risk in HBV and HCV Patients
|
|
Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic
Encephalopathy in HCV-Related Liver Cirrhosis
|
|
Serum Soluble CD163 as a Predictor of Esophageal Varices and
Variceal Bleeding in Cirrhotic Patients
|
|
Evaluation of MicroRNA-122 as a Biomarker for
Chronic Hepatitis C Infection and as a Predictor
for Treatment Response to Direct-Acting
Antivirals
|
|
Pancreatic Exocrine Insufficiency among Diabetic Patients
|